ZA945275B - Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor - Google Patents
Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding thereforInfo
- Publication number
- ZA945275B ZA945275B ZA945275A ZA945275A ZA945275B ZA 945275 B ZA945275 B ZA 945275B ZA 945275 A ZA945275 A ZA 945275A ZA 945275 A ZA945275 A ZA 945275A ZA 945275 B ZA945275 B ZA 945275B
- Authority
- ZA
- South Africa
- Prior art keywords
- cav
- virus
- vaccines
- induction
- proteins
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241000725585 Chicken anemia virus Species 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 208000015181 infectious disease Diseases 0.000 abstract 4
- 108020004414 DNA Proteins 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 230000006882 induction of apoptosis Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 230000003302 anti-idiotype Effects 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000003149 assay kit Methods 0.000 abstract 1
- 230000030833 cell death Effects 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL9301272A NL9301272A (nl) | 1993-07-20 | 1993-07-20 | Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA945275B true ZA945275B (en) | 1995-02-24 |
Family
ID=19862681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA945275A ZA945275B (en) | 1993-07-20 | 1994-07-19 | Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5952002A (fr) |
| EP (2) | EP1253201B1 (fr) |
| JP (1) | JP3829290B2 (fr) |
| AT (2) | ATE236980T1 (fr) |
| AU (1) | AU703187B2 (fr) |
| CA (1) | CA2167578C (fr) |
| DE (2) | DE69435117D1 (fr) |
| DK (2) | DK0784685T3 (fr) |
| ES (2) | ES2196032T3 (fr) |
| NL (1) | NL9301272A (fr) |
| PT (2) | PT1253201E (fr) |
| WO (1) | WO1995003414A2 (fr) |
| ZA (1) | ZA945275B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080234466A1 (en) * | 1990-09-12 | 2008-09-25 | Noteborn Mathieu H M | Delivery method for the tumor-specific apoptosis-inducing activity of apoptin |
| US6162461A (en) * | 1990-09-12 | 2000-12-19 | Leadd B.V. | Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| EP0872552A1 (fr) * | 1997-04-15 | 1998-10-21 | Leadd B.V. | Véhicules de transfert de gènes exprimant la protéine VP2 induisant l'apoptose, et/ou l'apoptine |
| EP0878546A1 (fr) * | 1997-04-15 | 1998-11-18 | Leadd B.V. | Véhicules de transfert de gènes exprimant la protéine VP2 induisant l'apoptose, et/ou l'apoptine |
| US5789567A (en) * | 1994-07-06 | 1998-08-04 | Cornell Research Foundation, Inc. | Chicken infectious anemia virus vaccine |
| GB9414888D0 (en) * | 1994-07-23 | 1994-09-14 | Univ Belfast | Method and composition |
| ES2200065T3 (es) * | 1995-06-07 | 2004-03-01 | Leadd B.V. | Utilizacion de apoptina. |
| JPH11510367A (ja) * | 1995-06-07 | 1999-09-14 | アエスキュラープ ビー．ヴィ． | ニワトリ貧血ウイルスの中和性立体配座エピトープ |
| EP0927757A1 (fr) * | 1997-12-03 | 1999-07-07 | Leadd B.V. | Méthodes et moyens pour induire l'apoptose par interférence avec des protéines similaires à Bip |
| US7361730B1 (en) * | 1999-03-15 | 2008-04-22 | University Of Maryland | Surface localized colligin/Hsp47 in carcinoma cells |
| EP1199363A1 (fr) * | 2000-10-20 | 2002-04-24 | Leadd B.V. | Modifications de l' apoptine par phosphorylation |
| AUPR567401A0 (en) * | 2001-06-14 | 2001-07-12 | University Of Melbourne, The | Circovirus vaccines |
| EP2275132B1 (fr) | 2005-12-29 | 2021-03-03 | Boehringer Ingelheim Animal Health USA Inc. | Composés immunogénique multivalent de PCV2 et leurs méthodes de préparation |
| EP2371382B1 (fr) | 2005-12-29 | 2016-03-02 | Boehringer Ingelheim Vetmedica, Inc. | Utilisation d'une composition immunogène PCV2 pour diminuer les symptômes cliniques chez les porcs |
| CN102311928B (zh) * | 2011-08-25 | 2013-04-24 | 中国农业科学院哈尔滨兽医研究所 | 鸡贫血病毒vp1、vp2蛋白共表达的重组酵母工程菌、其构建方法及应用 |
| JP7088835B2 (ja) | 2015-10-16 | 2022-06-21 | カンザス ステイト ユニバーシティ リサーチ ファウンデーション | ブタサーコウイルス３型免疫原性組成物、その製造方法、およびその使用方法 |
| WO2017187131A1 (fr) * | 2016-04-26 | 2017-11-02 | London School Of Hygiene & Tropical Medicine | Vaccin contre des reoviridae |
| CN113980146B (zh) * | 2021-11-11 | 2022-09-27 | 扬州优邦生物药品有限公司 | 三聚体化鸭黄病毒E蛋白domainIII、其制备方法和运用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL9002008A (nl) * | 1990-09-12 | 1992-04-01 | Stichting Centr Diergeneeskund | Recombinant dna en rna en daarvan afgeleide produkten. |
| ZA918426B (en) * | 1990-10-31 | 1992-12-30 | Akzo Nv | Chicken anemia virus vaccine and diagnostic |
| ZA927014B (en) * | 1991-09-20 | 1993-03-19 | Akzo Nv | Chicken anaemia agent vaccine. |
-
1993
- 1993-07-20 NL NL9301272A patent/NL9301272A/nl not_active Application Discontinuation
-
1994
- 1994-07-19 ZA ZA945275A patent/ZA945275B/xx unknown
- 1994-07-19 AU AU75473/94A patent/AU703187B2/en not_active Ceased
- 1994-07-19 EP EP01205103A patent/EP1253201B1/fr not_active Expired - Lifetime
- 1994-07-19 JP JP50507295A patent/JP3829290B2/ja not_active Expired - Lifetime
- 1994-07-19 AT AT94925638T patent/ATE236980T1/de not_active IP Right Cessation
- 1994-07-19 DE DE69435117T patent/DE69435117D1/de not_active Expired - Fee Related
- 1994-07-19 CA CA002167578A patent/CA2167578C/fr not_active Expired - Fee Related
- 1994-07-19 DK DK94925638T patent/DK0784685T3/da active
- 1994-07-19 DE DE69432486T patent/DE69432486T2/de not_active Expired - Fee Related
- 1994-07-19 AT AT01205103T patent/ATE401406T1/de not_active IP Right Cessation
- 1994-07-19 ES ES94925638T patent/ES2196032T3/es not_active Expired - Lifetime
- 1994-07-19 WO PCT/NL1994/000168 patent/WO1995003414A2/fr active IP Right Grant
- 1994-07-19 ES ES01205103T patent/ES2311005T3/es not_active Expired - Lifetime
- 1994-07-19 PT PT01205103T patent/PT1253201E/pt unknown
- 1994-07-19 DK DK01205103T patent/DK1253201T3/da active
- 1994-07-19 PT PT94925638T patent/PT784685E/pt unknown
- 1994-07-19 EP EP94925638A patent/EP0784685B1/fr not_active Expired - Lifetime
-
1997
- 1997-08-14 US US08/911,092 patent/US5952002A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995003414A3 (fr) | 1995-03-02 |
| AU7547394A (en) | 1995-02-20 |
| ATE401406T1 (de) | 2008-08-15 |
| EP0784685B1 (fr) | 2003-04-09 |
| JPH09504941A (ja) | 1997-05-20 |
| NL9301272A (nl) | 1995-02-16 |
| DK0784685T3 (da) | 2003-08-04 |
| ATE236980T1 (de) | 2003-04-15 |
| ES2196032T3 (es) | 2003-12-16 |
| DE69432486T2 (de) | 2004-03-04 |
| DK1253201T3 (da) | 2008-11-17 |
| PT1253201E (pt) | 2008-10-27 |
| EP1253201A2 (fr) | 2002-10-30 |
| EP1253201A3 (fr) | 2003-01-08 |
| WO1995003414A2 (fr) | 1995-02-02 |
| EP0784685A2 (fr) | 1997-07-23 |
| ES2311005T3 (es) | 2009-02-01 |
| CA2167578C (fr) | 2007-03-13 |
| DE69435117D1 (de) | 2008-08-28 |
| JP3829290B2 (ja) | 2006-10-04 |
| EP1253201B1 (fr) | 2008-07-16 |
| US5952002A (en) | 1999-09-14 |
| CA2167578A1 (fr) | 1995-02-02 |
| AU703187B2 (en) | 1999-03-18 |
| PT784685E (pt) | 2003-08-29 |
| DE69432486D1 (de) | 2003-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA945275B (en) | Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor | |
| BR9712592A (pt) | Processo para gerar um clone infeccioso, ácido nucléico recombinante, molécula do mesmo, vìrus de rna modificado, célula infectada com o mesmo, vacina, proteìna e/ou antìgeno, e, ensaio diagnóstico | |
| ES8500322A1 (es) | Un metodo de modificar un virus para conferirle una nueva funcion biologica. | |
| DE69519521T2 (de) | Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus | |
| DE69536039D1 (de) | Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert | |
| CY1115749T1 (el) | Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια | |
| DE69536138D1 (de) | Rekombinantes Herpesvirus aus Truthähnen und seine Verwendungen | |
| EP0201716A3 (en) | Expression of immunologically reactive viral proteins | |
| MXPA03002751A (es) | Fragmentos polipeptidicos del virus de la hepatitis e, composicion de vacuna y equipos de diagnostico que comprenden los mismos. | |
| EP0294469A4 (fr) | Vaccins et analyses diagnostiques pour l'haemophilus influenzae. | |
| DK0491824T4 (da) | Humane parvovirus B19-proteiner og viruslignende partikler, deres fremstilling og anvendelse til diagnostiske bestemmelser og vacciner | |
| EP0236977A3 (fr) | Vaccins contre la diarrhée bovine virale et le choléra porcin | |
| AU3379693A (en) | Vaccines and diagnostic assays for haemophilus influenzae | |
| ATE223492T1 (de) | Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe | |
| GR3003754T3 (fr) | ||
| ATE122096T1 (de) | Von babesia abgeleitete antigene und polypeptide (12d3-antigen). | |
| Li et al. | Cloning of HBV S Gene with Artificial Mutation Sites in ‘a’Determinant and Analyzing the Protein Antigenicity Expressed | |
| RU92004487A (ru) | Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов |